{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:49:58Z","timestamp":1794030598548,"version":"4.8.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.redox.2025.103666","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:14:59Z","timestamp":1746548099000},"page":"103666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hypoxia in multiple sclerosis"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-0151","authenticated-orcid":false,"given":"Johannes","family":"Burtscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Motl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Berek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Ehrenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Hohenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","article-title":"Genetics of multiple sclerosis","volume":"3","author":"Dyment","year":"2004","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"10076","key":"10.1016\/j.redox.2025.103666_bib5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/jnnp.2008.171132","article-title":"Multiple sclerosis","volume":"9","author":"Coles","year":"2009","journal-title":"Pract. Neurol."},{"issue":"14","key":"10.1016\/j.redox.2025.103666_bib8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"10422","key":"10.1016\/j.redox.2025.103666_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3132","article-title":"The evaluation of VEGF and HIF-1\u03b1 gene polymorphisms and multiple sclerosis susceptibility","volume":"21","author":"Saravani","year":"2019","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/biology8020037","article-title":"Mitochondrial dysfunction and multiple sclerosis","volume":"8","author":"Barcelos","year":"2019","journal-title":"Biology"},{"issue":"Pt 4","key":"10.1016\/j.redox.2025.103666_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/115.4.979","article-title":"Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation","volume":"115","author":"Harding","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.redox.2025.103666_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102687","article-title":"Association between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple Sclerosis: a meta-regression and meta-analysis","volume":"48","author":"Omraninava","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1179\/174313209X380928","article-title":"Down-regulation of interleukin 7 mRNA by hypoxia is calcium dependent","volume":"31","author":"Lu","year":"2009","journal-title":"Neurol. Res."},{"issue":"6578","key":"10.1016\/j.redox.2025.103666_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s42255-021-00341-7","article-title":"Diet-dependent regulation of TGF\u03b2 impairs reparative innate immune responses after demyelination","volume":"3","author":"Bosch-Queralt","year":"2021","journal-title":"Nat. Metab."},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40263-019-00674-8","article-title":"An update on vitamin D and disease activity in multiple sclerosis","volume":"33","author":"Smolders","year":"2019","journal-title":"CNS Drugs"},{"issue":"9648","key":"10.1016\/j.redox.2025.103666_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awaa427","article-title":"Hypoxia in multiple sclerosis; is it the chicken or the egg?","volume":"144","author":"Halder","year":"2021","journal-title":"Brain"},{"issue":"Pt 11","key":"10.1016\/j.redox.2025.103666_bib22","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.redox.2025.103666_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1552-6569.2011.00585.x","article-title":"The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis","volume":"22","author":"Holland","year":"2012","journal-title":"J. Neuroimaging"},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.redox.2025.103666_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"86","key":"10.1016\/j.redox.2025.103666_bib27","first-page":"53","article-title":"Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis","volume":"16","author":"Rodgers","year":"2013","journal-title":"Discov. Med."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib28","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.114.05003","article-title":"Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study","volume":"65","author":"Bilo","year":"2015","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181458","article-title":"Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study","volume":"12","author":"Bsteh","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","article-title":"Thinking outside the box: non-canonical targets in multiple sclerosis","volume":"21","author":"Bierhansl","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib36","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/brain\/awaa145","article-title":"The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history","volume":"143","author":"Sorensen","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1352458520914844","article-title":"The multiple sclerosis prodrome: emerging evidence, challenges, and opportunities","volume":"27","author":"Tremlett","year":"2021","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/WCO.0000000000000685","article-title":"The changing concepts in the neuropathology of acquired demyelinating central nervous system disorders","volume":"32","author":"Lassmann","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib41","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/glia.23726","article-title":"Pathology of inflammatory diseases of the nervous system: human disease versus animal models","volume":"68","author":"Lassmann","year":"2020","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib42","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/j.2040-4603.2018.tb00050.x","article-title":"Systemic oxygen transport with rest, exercise, and hypoxia: a comparison of humans, rats, and mice","volume":"8","author":"Gonzalez","year":"2018","journal-title":"Compr. Physiol."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib43","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2025.103666_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102550","article-title":"Neuronal deletion of MnSOD in mice leads to demyelination, inflammation and progressive paralysis that mimics phenotypes associated with progressive multiple sclerosis","volume":"59","author":"Bhaskaran","year":"2023","journal-title":"Redox Biol."},{"issue":"20","key":"10.1016\/j.redox.2025.103666_bib45","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1042\/CS20170981","article-title":"Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis","volume":"131","author":"Martinez Sosa","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"13","key":"10.1016\/j.redox.2025.103666_bib46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1177\/1352458518791683","article-title":"Multiple sclerosis disease progression: contributions from a hypoxia-inflammation cycle","volume":"25","author":"Yang","year":"2019","journal-title":"Mult. Scler."},{"issue":"Pt 3","key":"10.1016\/j.redox.2025.103666_bib47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.24632","article-title":"Demyelination and neurodegeneration in multiple sclerosis: the role of hypoxia","volume":"79","author":"Lassmann","year":"2016","journal-title":"Ann. Neurol."},{"issue":"13\u201315","key":"10.1016\/j.redox.2025.103666_bib49","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/ars.2021.0280","article-title":"Adaptive responses to hypoxia and\/or hyperoxia in humans","volume":"37","author":"Burtscher","year":"2022","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2025.103666_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2023.06.015","article-title":"Environmental and behavioral regulation of HIF-mitochondria crosstalk","volume":"206","author":"Burtscher","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103666_bib52","article-title":"The interplay of NAD and hypoxic stress and its relevance for ageing","author":"Burtscher","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"18","key":"10.1016\/j.redox.2025.103666_bib53","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp-2017-316011","article-title":"Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier","volume":"89","author":"Spencer","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib55","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/jcbfm.2015.131","article-title":"Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?","volume":"35","author":"D'Haeseleer","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167196","article-title":"Gray matter hypoxia in the brain of the experimental autoimmune encephalomyelitis model of multiple sclerosis","volume":"11","author":"Johnson","year":"2016","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.redox.2025.103666_bib57","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1073\/pnas.1920935117","article-title":"Chronic mild hypoxia accelerates recovery from preexisting EAE by enhancing vascular integrity and apoptosis of infiltrated monocytes","volume":"117","author":"Halder","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib58","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.24006","article-title":"Neurological deficits caused by tissue hypoxia in neuroinflammatory disease","volume":"74","author":"Davies","year":"2013","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib59","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458512460602","article-title":"Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination","volume":"19","author":"Nathoo","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.redox.2025.103666_bib60","article-title":"Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2025.103666_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-031-14190-4_15","article-title":"Non-invasive detection of persistent cortical hypoxia in multiple sclerosis using frequency domain near-infrared spectroscopy (fdNIRS)","volume":"1395","author":"Adingupu","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ana.26769","article-title":"Temporal pattern of cortical hypoxia in multiple sclerosis and its significance on neuropsychological and clinical measures of disability","volume":"94","author":"Adingupu","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-031-14190-4_25","article-title":"NIRS studies show reduced interhemispheric functional connectivity in individuals with multiple sclerosis that exhibit cortical hypoxia","volume":"1395","author":"Soroush","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/62.1.25","article-title":"Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases","volume":"62","author":"Aboul-Enein","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.redox.2025.103666_bib65","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/1352458512438455","article-title":"Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis","volume":"18","author":"McMahon","year":"2012","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/1352458511399114","article-title":"Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis","volume":"17","author":"Cunnea","year":"2011","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/NEN.0b013e318165b239","article-title":"Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions","volume":"67","author":"Mh\u00e1ille","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-022-01337-4","article-title":"Mapping of neuroinflammation-induced hypoxia in the spinal cord using optoacoustic imaging","volume":"10","author":"Ramos-Vega","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib69","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/acn3.52150","article-title":"Investigating cortical hypoxia in multiple sclerosis via time-domain near-infrared spectroscopy","volume":"11","author":"Williams","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib70","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/bpa.12460","article-title":"Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis","volume":"27","author":"Geraldes","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.redox.2025.103666_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2013.09.009","article-title":"Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the \u03b15\u03b21 integrin","volume":"250","author":"Boroujerdi","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-2094-7-95","article-title":"Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions","volume":"7","author":"Seabrook","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2009.12.059","article-title":"Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter","volume":"470","author":"Holley","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ana.25749","article-title":"Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis","volume":"88","author":"Desai","year":"2020","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib75","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-004-0954-8","article-title":"Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?","volume":"109","author":"Aboul-Enein","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"Pt 7","key":"10.1016\/j.redox.2025.103666_bib77","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib78","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.2582","article-title":"Enhanced number and activity of mitochondria in multiple sclerosis lesions","volume":"219","author":"Witte","year":"2009","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12851","article-title":"Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis","volume":"49","author":"Licht-Mayer","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann. Neurol."},{"issue":"17","key":"10.1016\/j.redox.2025.103666_bib82","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1523\/JNEUROSCI.4077-15.2016","article-title":"Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival","volume":"36","author":"Rone","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1124774","article-title":"The hypoxic tissue microenvironment as a driver of mucosal inflammatory resolution","volume":"14","author":"Cartwright","year":"2023","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.redox.2025.103666_bib85","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1113\/JP285230","article-title":"Mechanisms underlying the health benefits of intermittent hypoxia conditioning","volume":"602","author":"Burtscher","year":"2024","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib86","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/glia.24381","article-title":"Acute intermittent hypoxia alters disease course and promotes CNS repair including resolution of inflammation and remyelination in the experimental autoimmune encephalomyelitis model of MS","volume":"71","author":"Tokarska","year":"2023","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-018-0590-5","article-title":"Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels","volume":"6","author":"Halder","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib88","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1096\/fj.201700524R","article-title":"Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37","volume":"31","author":"Giacoppo","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2025.103666_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-015-0407-4","article-title":"Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE","volume":"13","author":"Esen","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.redox.2025.103666_bib90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4419-7756-4_23","article-title":"Chronic mild hypoxia ameliorates chronic inflammatory activity in myelin oligodendrocyte glycoprotein (MOG) peptide induced experimental autoimmune encephalomyelitis (EAE)","volume":"701","author":"Dore-Duffy","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.redox.2025.103666_bib91","doi-asserted-by":"crossref","first-page":"taae112","DOI":"10.1093\/jtm\/taae112","article-title":"Cognitive effects of altitude exposure","volume":"22","author":"Burtscher","year":"2024","journal-title":"J. Trav. Med."},{"issue":"21","key":"10.1016\/j.redox.2025.103666_bib92","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1113\/JP284550","article-title":"Expedition 5300: limits of human adaptations in the highest city in the world","volume":"602","author":"Champigneulle","year":"2024","journal-title":"J. Physiol."},{"key":"10.1016\/j.redox.2025.103666_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.647822","article-title":"Mice and rats display different ventilatory, hematological, and metabolic features of acclimatization to hypoxia","volume":"12","author":"Arias-Reyes","year":"2021","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physiolgenomics.00081.2001","article-title":"Hypoxia induces different genes in the lungs of rats compared with mice","volume":"12","author":"Hoshikawa","year":"2003","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.redox.2025.103666_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.118935","article-title":"Abnormal oxidative metabolism in the cuprizone mouse model of demyelination: an in vivo NIRS-MRI study","volume":"250","author":"Hashem","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.redox.2025.103666_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104994","article-title":"Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis","volume":"143","author":"Navarrete","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2025.103666_bib97","article-title":"Acute intermittent hypoxia induces motor and cognitive plasticity in persons with relapsing remitting multiple sclerosis","author":"Sandhu","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.redox.2025.103666_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104647","article-title":"Acute intermittent hypoxia and ue strength and function changes in multiple sclerosis: a case report","volume":"73","author":"Thornton","year":"2023","journal-title":"Multiple Scleros. Related Disorders"},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib99","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/a-1273-8304","article-title":"Neuromuscular and mobility responses to a vibration session in hypoxia in multiple sclerosis","volume":"42","author":"Andreu-Caravaca","year":"2021","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.redox.2025.103666_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02819","article-title":"Metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: a pilot study","volume":"9","author":"M\u00e4hler","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib101","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1007\/s00415-021-10596-5","article-title":"Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study","volume":"268","author":"Zrzavy","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib102","first-page":"265","article-title":"Effekte eines Ausdauertrainings unter normobaren Hypoxiebedingungen auf die Mobilit\u00e4t bei Patienten mit Multipler Sklerose: ergebnisse einer randomisierten, prospektiven Pilotstudie","volume":"20","author":"Pfitzner","year":"2014","journal-title":"Neurol. Rehabil."},{"issue":"2S","key":"10.1016\/j.redox.2025.103666_bib103","first-page":"56","article-title":"Sprint-Interval-Training under hypoxia in persons with Multiple Sclerosis: a feasibility study","volume":"30","author":"Adammek","year":"2024","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.redox.2025.103666_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101343","article-title":"Hypoxia and brain aging: neurodegeneration or neuroprotection?","volume":"68","author":"Burtscher","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/nep3.47","article-title":"Tolerability and first hints for potential efficacy of motor-cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: a translational viewpoint","volume":"2","author":"Mennen","year":"2024","journal-title":"Neuroprotection"},{"key":"10.1016\/j.redox.2025.103666_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28544","article-title":"Hypoxia conditioning as a promising therapeutic target in Parkinson's disease?","author":"Burtscher","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib107","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12883-024-03702-3","article-title":"Randomized controlled trial of intermittent hypoxia in Parkinson's disease: study rationale and protocol","volume":"24","author":"Janssen Daalen","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113891","article-title":"Therapeutic acute intermittent hypoxia: a translational roadmap for spinal cord injury and neuromuscular disease","volume":"347","author":"Vose","year":"2022","journal-title":"Exp. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.redox.2025.103666_bib109","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awh457","article-title":"Tissue preconditioning may explain concentric lesions in Bal\u00f3's type of multiple sclerosis","volume":"128","author":"Stadelmann","year":"2005","journal-title":"Brain"},{"issue":"19","key":"10.1016\/j.redox.2025.103666_bib110","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1212\/WNL.0000000000003308","article-title":"Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development","volume":"87","author":"Takai","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/acn3.572","article-title":"7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions","volume":"5","author":"Behrens","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"Pt 11","key":"10.1016\/j.redox.2025.103666_bib112","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awm236","article-title":"Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?","volume":"130","author":"Marik","year":"2007","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib113","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"46","key":"10.1016\/j.redox.2025.103666_bib114","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1073\/pnas.1318345110","article-title":"Hypoxia and inflammation are two sides of the same coin","volume":"110","author":"Bartels","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11940-024-00816-4","article-title":"A hypoxia-inflammation cycle and multiple sclerosis: mechanisms and therapeutic implications","volume":"27","author":"Soroush","year":"2025","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105002","article-title":"Home-based exercise improves subclinical atherosclerosis marker in multiple sclerosis","volume":"79","author":"Baynard","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2004-0314OC","article-title":"Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells","volume":"32","author":"Krick","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.redox.2025.103666_bib118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-6-26","article-title":"Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway","volume":"6","author":"Luo","year":"2006","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib119","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Niki\u0107","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2025.103666_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/srep33249","article-title":"Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis","volume":"6","author":"Sadeghian","year":"2016","journal-title":"Sci. Rep."},{"issue":"42","key":"10.1016\/j.redox.2025.103666_bib121","doi-asserted-by":"crossref","first-page":"31950","DOI":"10.1074\/jbc.M603717200","article-title":"Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis","volume":"281","author":"Qi","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt 7","key":"10.1016\/j.redox.2025.103666_bib122","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/brain\/awr110","article-title":"Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis","volume":"134","author":"Zambonin","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib123","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/135245859800400503","article-title":"Oxidative damage to DNA in plaques of MS brains","volume":"4","author":"Vladimirova","year":"1998","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib124","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-012-1052-y","article-title":"Reduced expression of PGC-1\u03b1 partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex","volume":"125","author":"Witte","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.redox.2025.103666_bib125","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/brain\/awz201","article-title":"A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis","volume":"142","author":"Wentling","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib126","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-Derived sphingolipids interact with mff and promote mitochondrial fragmentation in obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.redox.2025.103666_bib127","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020582","article-title":"A rationale for hypoxic and chemical conditioning in huntington's disease","volume":"22","author":"Burtscher","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib129","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/brain\/awaa049","article-title":"Anterior visual system imaging to investigate energy failure in multiple sclerosis","volume":"143","author":"Kleerekooper","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1352458510364196","article-title":"Cerebrospinal fluid ATP metabolites in multiple sclerosis","volume":"16","author":"Lazzarino","year":"2010","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib131","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbadis.2014.04.005","article-title":"Serum lactate as a novel potential biomarker in multiple sclerosis","volume":"1842","author":"Amorini","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021698","article-title":"Molecular mechanisms of high-altitude acclimatization","volume":"24","author":"Mallet","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib134","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.redox.2025.103666_bib136","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.M800102200","article-title":"Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.redox.2025.103666_bib137","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2013.06.004","article-title":"Induction of vascular remodeling: a novel therapeutic approach in EAE","volume":"333","author":"Esen","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13221-014-0023-6","article-title":"The role of angiogenesis in the pathology of multiple sclerosis","volume":"6","author":"Lengfeld","year":"2014","journal-title":"Vasc. Cell"},{"key":"10.1016\/j.redox.2025.103666_bib139","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/B:MEBR.0000043969.96895.3c","article-title":"Erythropoietin: novel approaches to neuroprotection in human brain disease","volume":"19","author":"Ehrenreich","year":"2004","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(02)03239-0","article-title":"Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis","volume":"952","author":"Agnello","year":"2002","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib141","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.20274","article-title":"Beneficial effect of erythropoietin on experimental allergic encephalomyelitis","volume":"56","author":"Li","year":"2004","journal-title":"Ann. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.redox.2025.103666_bib142","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ."},{"issue":"Pt 2","key":"10.1016\/j.redox.2025.103666_bib143","first-page":"375","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.redox.2025.103666_bib144","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","article-title":"Erythropoietin treatment improves neurological functional recovery in EAE mice","volume":"1034","author":"Zhang","year":"2005","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.redox.2025.103666_bib145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2005.10.016","article-title":"Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis","volume":"172","author":"Savino","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"Pt 10","key":"10.1016\/j.redox.2025.103666_bib146","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/brain\/awm203","article-title":"Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis","volume":"130","author":"Ehrenreich","year":"2007","journal-title":"Brain"},{"issue":"5\u20136","key":"10.1016\/j.redox.2025.103666_bib147","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neucli.2013.09.004","article-title":"Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: a pilot, open-label study with neurophysiological measurements","volume":"43","author":"Cr\u00e9ange","year":"2013","journal-title":"Neurophysiol. Clin."},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib148","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13760-014-0286-y","article-title":"Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis","volume":"114","author":"Najmi Varzaneh","year":"2014","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib149","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/1352458516661048","article-title":"High-dose erythropoietin in patients with progressive multiple sclerosis: a randomized, placebo-controlled, phase 2 trial","volume":"23","author":"Schreiber","year":"2017","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/1352458517733132","article-title":"How to pursue EPO in MS","volume":"24","author":"Bartels","year":"2018","journal-title":"Mult. Scler."},{"issue":"1\u20132","key":"10.1016\/j.redox.2025.103666_bib151","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mvr.2004.11.004","article-title":"The CNS pericyte response to low oxygen: early synthesis of cyclopentenone prostaglandins of the J-series","volume":"69","author":"Dore-Duffy","year":"2005","journal-title":"Microvasc. Res."},{"issue":"10","key":"10.1016\/j.redox.2025.103666_bib152","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2014.1668","article-title":"Impaired cerebrovascular reactivity in multiple sclerosis","volume":"71","author":"Marshall","year":"2014","journal-title":"JAMA Neurol."},{"issue":"21","key":"10.1016\/j.redox.2025.103666_bib153","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1113\/JP284608","article-title":"Recent insights into mechanisms of hypoxia-induced vasodilatation in the human brain","volume":"602","author":"Carr","year":"2024","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib154","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103666_bib155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-0320-7_15","article-title":"Examining vascular remodeling in the hypoxic central nervous system","volume":"1135","author":"Boroujerdi","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib156","doi-asserted-by":"crossref","first-page":"R832","DOI":"10.1152\/ajpregu.00200.2022","article-title":"Hypoxic preconditioning reduces endothelial ischemia-reperfusion injury in older adults","volume":"323","author":"Stray-Gundersen","year":"2022","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib157","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1152\/japplphysiol.00772.2020","article-title":"Hypoxic preconditioning attenuates ischemia-reperfusion injury in young healthy adults","volume":"130","author":"Jarrard","year":"2021","journal-title":"J. Appl. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib158","doi-asserted-by":"crossref","first-page":"R398","DOI":"10.1152\/ajpregu.00270.2015","article-title":"Hypoxemia, oxygen content, and the regulation of cerebral blood flow","volume":"310","author":"Hoiland","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"12","key":"10.1016\/j.redox.2025.103666_bib159","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/1535370216649060","article-title":"Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease","volume":"241","author":"Manukhina","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.redox.2025.103666_bib160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2013.12.007","article-title":"Non-pharmaceutical therapies for stroke: mechanisms and clinical implications","volume":"115","author":"Chen","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib161","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1113\/jphysiol.2013.268953","article-title":"Integrative regulation of human brain blood flow","volume":"592","author":"Willie","year":"2014","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib162","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1177\/0271678X221075967","article-title":"Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans","volume":"42","author":"Bailey","year":"2022","journal-title":"J. Cerebr. Blood Flow Metabol. : Off. J. Int. Soc. Cerebral Blood Flow Metabol."},{"issue":"8","key":"10.1016\/j.redox.2025.103666_bib163","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2025.103666_bib164","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X231185507","article-title":"Intermittent hypoxia protects against hypoxic-ischemic brain damage by inducing functional angiogenesis","author":"Guan","year":"2023","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib165","first-page":"370","article-title":"Effects of hypoxia on cerebral microvascular angiogenesis: benefits or damages?","volume":"14","author":"Guan","year":"2023","journal-title":"Aging Dis"},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib166","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005053-195810000-00002","article-title":"Pharmacological reduction of abnormality in multiple sclerosis within minutes: a statistical study","volume":"127","author":"Brickner","year":"1958","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib167","first-page":"550","article-title":"Multiple sclerosis; treatment with histamine and d-tubocurarine","volume":"6","author":"Jonez","year":"1948","journal-title":"Ann. Allergy"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/smrv.2002.0261","article-title":"Obstructive sleep apnoea syndrome\u2013an oxidative stress disorder","volume":"7","author":"Lavie","year":"2003","journal-title":"Sleep Med. Rev."},{"issue":"19","key":"10.1016\/j.redox.2025.103666_bib169","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1074\/jbc.273.19.11619","article-title":"Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes","volume":"273","author":"Duranteau","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.33549\/physiolres.930000.49.89","article-title":"Role of nitric oxide in adaptation to hypoxia and adaptive defense","volume":"49","author":"Manukhina","year":"2000","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib171","first-page":"1","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"L\u00e9vy","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.redox.2025.103666_bib172","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fneur.2017.00740","article-title":"Sleep-disordered breathing in people with multiple sclerosis: prevalence, pathophysiological mechanisms, and disease consequences","volume":"8","author":"Hensen","year":"2017","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.redox.2025.103666_bib173","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/13524585231169465","article-title":"Sleep-disordered breathing and neurocognitive function in multiple sclerosis: differential associations across cognitive domains","volume":"29","author":"Valentine","year":"2023","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib174","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.niox.2010.08.005","article-title":"Adaptation to intermittent hypoxia restricts nitric oxide overproduction and prevents beta-amyloid toxicity in rat brain","volume":"23","author":"Goryacheva","year":"2010","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/niox.1999.0244","article-title":"Production and storage of nitric oxide in adaptation to hypoxia","volume":"3","author":"Manukhina","year":"1999","journal-title":"Nitric Oxide"},{"issue":"13\u201315","key":"10.1016\/j.redox.2025.103666_bib176","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/ars.2021.0280","article-title":"Adaptive responses to hypoxia and\/or hyperoxia in humans","volume":"37","author":"Burtscher","year":"2022","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.redox.2025.103666_bib177","first-page":"1","article-title":"Intermittent not continuous hypoxia provoked haematological adaptations in healthy seniors: hypoxic pattern may hold the key","author":"Tobin","year":"2020","journal-title":"Eur. J. Appl. Physiol."},{"issue":"21","key":"10.1016\/j.redox.2025.103666_bib178","doi-asserted-by":"crossref","first-page":"E4241","DOI":"10.1073\/pnas.1621511114","article-title":"Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome","volume":"114","author":"Ferrari","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib179","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2021.03.005","article-title":"Hypoxia ameliorates brain hyperoxia and NAD(+) deficiency in a murine model of Leigh syndrome","volume":"133","author":"Grange","year":"2021","journal-title":"Mol. Genet. Metabol."},{"issue":"6281","key":"10.1016\/j.redox.2025.103666_bib180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/science.aad9642","article-title":"Hypoxia as a therapy for mitochondrial disease","volume":"352","author":"Jain","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.redox.2025.103666_bib181","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cell.2019.03.045","article-title":"Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis","volume":"177","author":"Ast","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib182","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2023.12.010","article-title":"Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism","volume":"187","author":"Meisel","year":"2024","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.redox.2025.103666_bib183","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddad091","article-title":"Continuous, but not intermittent, regimens of hypoxia prevent and reverse ataxia in a murine model of Friedreich's ataxia","volume":"32","author":"Ast","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"782","key":"10.1016\/j.redox.2025.103666_bib184","doi-asserted-by":"crossref","first-page":"eadr4049","DOI":"10.1126\/scitranslmed.adr4049","article-title":"Hypoxia as a medicine","volume":"17","author":"Rogers","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.redox.2025.103666_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002117","article-title":"Hypoxia extends lifespan and neurological function in a mouse model of aging","volume":"21","author":"Rogers","year":"2023","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib186","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12868","article-title":"Oxygen treatment reduces neurological deficits and demyelination in two animal models of multiple sclerosis","volume":"49","author":"Amatruda","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.redox.2025.103666_bib187","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.24607","article-title":"Cause and prevention of demyelination in a model multiple sclerosis lesion","volume":"79","author":"Desai","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2025.103666_bib188","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.12688\/f1000research.11839.1","article-title":"Experimental autoimmune encephalomyelitis from a tissue energy perspective","volume":"6","author":"Desai","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.redox.2025.103666_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101343","article-title":"Hypoxia and brain aging: neurodegeneration or neuroprotection?","volume":"68","author":"Burtscher","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"28","key":"10.1016\/j.redox.2025.103666_bib191","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1523\/JNEUROSCI.2295-10.2010","article-title":"Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner","volume":"30","author":"Sun","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib192","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10534-018-0111-9","article-title":"Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin","volume":"31","author":"Zakharova","year":"2018","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.redox.2025.103666_bib193","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1756285614564152","article-title":"Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview","volume":"8","author":"Bomprezzi","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib194","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2014.02.062","article-title":"Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1)","volume":"448","author":"Zhao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2025.103666_bib195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2016.01.023","article-title":"Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway","volume":"105","author":"Lin-Holderer","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.redox.2025.103666_bib196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.expneurol.2015.02.022","article-title":"Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity","volume":"266","author":"Kunze","year":"2015","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2025.103666_bib197","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.26555","article-title":"Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome","volume":"93","author":"Okuda","year":"2023","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.redox.2025.103666_bib198","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/cmi.2017.12","article-title":"IL-17-triggered downregulation of miR-497 results in high HIF-1\u03b1 expression and consequent IL-1\u03b2 and IL-6 production by astrocytes in EAE mice","volume":"14","author":"Shan","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.redox.2025.103666_bib199","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0050-14.2015","article-title":"Hypoxia inducible factor-1\u03b1 in astrocytes and\/or myeloid cells is not required for the development of autoimmune demyelinating disease","volume":"2","author":"Le Moan","year":"2015","journal-title":"eNeuro"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172500179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172500179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:07:06Z","timestamp":1749730026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172500179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":199,"alternative-id":["S221323172500179X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103666","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103666"}}